Monday, November 30, 2009

Suven gets 3 European patents on NCEs for neurodegenerative disorders

Suven Life Sciences Ltd (Suven) announces that the European Patent Office (EPO) has issued three new patents: EP1537113, EP1704154 and EP1856132 corresponding to three New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases and these Patents are valid until 2022,23 and 24 respectively.

The details can be read here.

No comments: